Northland Securities Estimates Spectral AI FY2027 Earnings

Spectral AI, Inc. (NASDAQ:MDAI) – Investment analysts at Northland Securities reduced their FY2027 EPS estimates for Spectral AI in a research report issued to clients and investors on Wednesday, November 11th. Northland Securities analyst L. Horton now anticipates that the company will earn ($0.35) per share for the year, down from their previous estimate of ($0.34). Northland Securities has a “Strong-Buy” rating on the stock. The consensus estimate for Spectral AI’s current full-year earnings is ($0.50) per share.

Spectral AI (NASDAQ:MDAI) last announced its quarterly earnings results on Tuesday, November 10th. The company reported ($0.14) EPS for the quarter, meeting analysts’ consensus estimates of ($0.14). The firm had revenue of $2.86 million during the quarter, compared to analyst estimates of $5.33 million.

Several other equities research analysts also recently issued reports on MDAI. Wall Street Zen upgraded shares of Spectral AI from a “sell” rating to a “hold” rating in a research note on Saturday, September 12th. Weiss Ratings raised Spectral AI from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, October 28th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, Spectral AI has a consensus rating of “Moderate Buy” and an average target price of $4.00.

Spectral AI Price Performance

Spectral AI stock opened at $1.35 on Friday. The company’s 50-day moving average is $1.57 and its 200-day moving average is $1.69. The firm has a market capitalization of $43.46 million, a PE ratio of -4.09 and a beta of 1.25. Spectral AI has a fifty-two week low of $1.18 and a fifty-two week high of $2.97.

Institutional Investors Weigh In On Spectral AI

An institutional investor recently bought a new position in Spectral AI stock. Rathbones Group PLC acquired a new position in shares of Spectral AI, Inc. (NASDAQ:MDAI) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 87,045 shares of the company’s stock, valued at approximately $144,000. Rathbones Group PLC owned 0.27% of Spectral AI at the end of the most recent reporting period. Institutional investors and hedge funds own 67.08% of the company’s stock.

About Spectral AI

Spectral AI, Inc. is a medical diagnostic technology company focused on using artificial intelligence and advanced imaging to support earlier, more objective assessment of wound healing. The company develops predictive diagnostic systems intended to help clinicians evaluate wounds and make treatment decisions. Its principal product is the DeepView System, a noninvasive imaging and artificial intelligence platform designed to assess burn wounds and predict the likelihood that injured tissue will heal without surgical intervention.